Current options in antifungal pharmacotherapy
Infections caused by yeasts and molds continue to be associated with high rates of morbidity
and mortality in both immunocompromised and immunocompetent patients. Many antifungal …
and mortality in both immunocompromised and immunocompetent patients. Many antifungal …
Current options in antifungal pharmacotherapy.
J Mohr, M Johnson, T Cooper, JS Lewis… - …, 2008 - europepmc.org
Infections caused by yeasts and molds continue to be associated with high rates of morbidity
and mortality in both immunocompromised and immunocompetent patients. Many antifungal …
and mortality in both immunocompromised and immunocompetent patients. Many antifungal …
[引用][C] Current Options in Antifungal Pharmacotherapy
J MOHR, M JOHNSON, T COOPER… - …, 2008 - pascal-francis.inist.fr
Current Options in Antifungal Pharmacotherapy CNRS Inist Pascal-Francis CNRS Pascal
and Francis Bibliographic Databases Simple search Advanced search Search by …
and Francis Bibliographic Databases Simple search Advanced search Search by …
Current options in antifungal pharmacotherapy
J Mohr, M Johnson, T Cooper, JS Lewis… - …, 2008 - pubmed.ncbi.nlm.nih.gov
Infections caused by yeasts and molds continue to be associated with high rates of morbidity
and mortality in both immunocompromised and immunocompetent patients. Many antifungal …
and mortality in both immunocompromised and immunocompetent patients. Many antifungal …